BORDONARO, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 99
NA - Nord America 71
EU - Europa 34
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 4
AF - Africa 3
Totale 227
Nazione #
US - Stati Uniti d'America 68
SG - Singapore 40
CN - Cina 27
IT - Italia 17
HK - Hong Kong 10
VN - Vietnam 10
FR - Francia 6
AT - Austria 5
DE - Germania 5
ID - Indonesia 5
BR - Brasile 3
IN - India 3
CA - Canada 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
EG - Egitto 1
FI - Finlandia 1
IQ - Iraq 1
KE - Kenya 1
MN - Mongolia 1
NI - Nicaragua 1
TR - Turchia 1
Totale 211
Città #
San Jose 18
Ashburn 11
Hong Kong 10
Singapore 9
Ho Chi Minh City 4
Turin 4
Vienna 4
Beijing 3
Phoenix 3
Bologna 2
Hanoi 2
Hillsboro 2
Marseille 2
Messina 2
Milan 2
Ajman 1
Bandung 1
Banyuwangi 1
Bientina 1
Cairo 1
Chandigarh 1
Chennai 1
Chicago 1
Denpasar 1
Des Moines 1
Frankfurt am Main 1
Garbagnate Milanese 1
Haiphong 1
Hartford 1
Helsinki 1
Hải Dương 1
Inajá 1
Jakarta 1
Joinville 1
Lake Worth 1
Lexington 1
Luanda 1
Managua 1
Manassas 1
Memphis 1
Mersin 1
Montreal 1
New York 1
Nixa 1
Orem 1
Piscataway 1
Plano 1
Pune 1
Quảng Ngãi 1
Reston 1
Río Gallegos 1
Santa Clara 1
Surabaya 1
São Paulo 1
Ulan Bator 1
Williamston 1
Totale 119
Nome #
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 22
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 22
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 18
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 18
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 17
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 16
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 16
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 15
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 14
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 14
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 12
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 12
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 11
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 10
Tromboembolismo in oncologia medica 10
Totale 227
Categoria #
all - tutte 1.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026214 0 0 0 18 39 52 12 37 23 24 6 3
2026/202713 3 10 0 0 0 0 0 0 0 0 0 0
Totale 227